Baxter Cost Of Revenue vs Current Deferred Revenue Analysis

BAX Stock

USD 36.89 0.02 0.05%

Baxter International financial indicator trend analysis is way more than just evaluating Baxter International prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Baxter International is a good investment. Please check the relationship between Baxter International Cost Of Revenue and its Current Deferred Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Baxter International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Baxter Stock please use our How to Invest in Baxter International guide.

Cost Of Revenue vs Current Deferred Revenue

Cost Of Revenue vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Baxter International Cost Of Revenue account and Current Deferred Revenue. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Baxter International's Cost Of Revenue and Current Deferred Revenue is -0.56. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Baxter International, assuming nothing else is changed. The correlation between historical values of Baxter International's Cost Of Revenue and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Baxter International are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Cost Of Revenue i.e., Baxter International's Cost Of Revenue and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

-0.56

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Baxter International income statement and represents the costs associated with goods and services Baxter International provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from Baxter International's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Baxter International current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Baxter International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Baxter Stock please use our How to Invest in Baxter International guide.Selling General Administrative is likely to drop to about 2.4 B in 2024. Discontinued Operations is likely to rise to about (5.1 M) in 2024

	2021	2022	2023	2024 (projected)
Interest Expense	192M	395M	512M	537.6M
Depreciation And Amortization	890M	1.4B	1.3B	654.2M

Interest Expense Depreciation And Amortization

Baxter International fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock	Common Stock Total Equity
Total Assets		0.76	0.48	0.75	0.55	0.68	0.71	0.51	0.45	0.96	0.13	0.27	0.89	0.29	0.83	0.73	0.44	-0.58	0.97	0.76	0.73	0.37	0.57	0.37	0.61	0.62
Short Long Term Debt Total	0.76		0.32	0.49	0.09	0.3	0.99	0.47	0.0	0.83	0.19	-0.08	0.67	0.15	0.98	0.51	0.25	-0.64	0.84	0.96	0.32	0.61	0.93	0.59	0.29	0.37
Other Current Liab	0.48	0.32		0.49	0.06	0.71	0.27	0.13	0.34	0.47	0.48	-0.26	0.75	0.18	0.44	0.82	0.47	-0.12	0.52	0.42	0.32	0.02	0.13	0.38	0.24	0.25
Total Current Liabilities	0.75	0.49	0.49		0.43	0.71	0.44	0.22	0.37	0.57	0.21	0.47	0.81	0.44	0.51	0.82	0.67	-0.22	0.72	0.55	0.89	0.65	0.22	0.11	0.58	0.62
Total Stockholder Equity	0.55	0.09	0.06	0.43		0.53	-0.03	0.69	0.8	0.4	-0.22	0.66	0.42	0.61	0.14	0.24	0.45	-0.48	0.31	0.17	0.7	0.06	-0.08	-0.2	0.83	0.79
Property Plant And Equipment Net	0.68	0.3	0.71	0.71	0.53		0.22	0.37	0.55	0.56	0.17	0.2	0.84	0.5	0.44	0.88	0.4	-0.25	0.61	0.41	0.72	0.14	0.0	0.17	0.62	0.56
Net Debt	0.71	0.99	0.27	0.44	-0.03	0.22		0.35	-0.15	0.8	0.17	-0.15	0.61	0.03	0.96	0.46	0.17	-0.57	0.82	0.92	0.24	0.6	0.95	0.63	0.17	0.25
Retained Earnings	0.51	0.47	0.13	0.22	0.69	0.37	0.35		0.58	0.51	-0.13	0.15	0.47	0.65	0.46	0.2	0.38	-0.9	0.37	0.57	0.33	0.21	0.38	0.12	0.79	0.82
Cash	0.45	0.0	0.34	0.37	0.8	0.55	-0.15	0.58		0.31	0.05	0.49	0.46	0.53	0.08	0.33	0.5	-0.39	0.26	0.1	0.6	-0.1	-0.21	-0.25	0.74	0.71
Non Current Assets Total	0.96	0.83	0.47	0.57	0.4	0.56	0.8	0.51	0.31		0.13	0.02	0.83	0.13	0.9	0.65	0.33	-0.61	0.96	0.81	0.49	0.27	0.71	0.54	0.46	0.48
Non Currrent Assets Other	0.13	0.19	0.48	0.21	-0.22	0.17	0.17	-0.13	0.05	0.13		-0.14	0.32	0.17	0.24	0.33	0.33	0.09	0.21	0.2	0.1	0.02	0.09	-0.03	0.05	0.05
Cash And Short Term Investments	0.27	-0.08	-0.26	0.47	0.66	0.2	-0.15	0.15	0.49	0.02	-0.14		0.08	0.4	-0.1	0.0	0.26	-0.09	0.1	-0.12	0.76	0.32	-0.27	-0.53	0.51	0.47
Net Receivables	0.89	0.67	0.75	0.81	0.42	0.84	0.61	0.47	0.46	0.83	0.32	0.08		0.45	0.76	0.93	0.57	-0.47	0.88	0.76	0.69	0.35	0.43	0.34	0.64	0.66
Common Stock Shares Outstanding	0.29	0.15	0.18	0.44	0.61	0.5	0.03	0.65	0.53	0.13	0.17	0.4	0.45		0.18	0.34	0.53	-0.41	0.14	0.33	0.56	0.27	-0.05	-0.39	0.85	0.84
Non Current Liabilities Total	0.83	0.98	0.44	0.51	0.14	0.44	0.96	0.46	0.08	0.9	0.24	-0.1	0.76	0.18		0.61	0.23	-0.61	0.9	0.95	0.37	0.48	0.88	0.58	0.33	0.38
Inventory	0.73	0.51	0.82	0.82	0.24	0.88	0.46	0.2	0.33	0.65	0.33	0.0	0.93	0.34	0.61		0.5	-0.19	0.75	0.6	0.64	0.33	0.25	0.35	0.44	0.45
Other Current Assets	0.44	0.25	0.47	0.67	0.45	0.4	0.17	0.38	0.5	0.33	0.33	0.26	0.57	0.53	0.23	0.5		-0.23	0.36	0.42	0.54	0.43	0.13	0.02	0.6	0.69
Other Stockholder Equity	-0.58	-0.64	-0.12	-0.22	-0.48	-0.25	-0.57	-0.9	-0.39	-0.61	0.09	-0.09	-0.47	-0.41	-0.61	-0.19	-0.23		-0.5	-0.66	-0.27	-0.31	-0.57	-0.26	-0.64	-0.68
Total Liab	0.97	0.84	0.52	0.72	0.31	0.61	0.82	0.37	0.26	0.96	0.21	0.1	0.88	0.14	0.9	0.75	0.36	-0.5		0.81	0.61	0.41	0.67	0.49	0.43	0.45
Property Plant And Equipment Gross	0.76	0.96	0.42	0.55	0.17	0.41	0.92	0.57	0.1	0.81	0.2	-0.12	0.76	0.33	0.95	0.6	0.42	-0.66	0.81		0.36	0.62	0.88	0.56	0.42	0.52
Total Current Assets	0.73	0.32	0.32	0.89	0.7	0.72	0.24	0.33	0.6	0.49	0.1	0.76	0.69	0.56	0.37	0.64	0.54	-0.27	0.61	0.36		0.47	0.02	-0.16	0.73	0.7
Short Term Debt	0.37	0.61	0.02	0.65	0.06	0.14	0.6	0.21	-0.1	0.27	0.02	0.32	0.35	0.27	0.48	0.33	0.43	-0.31	0.41	0.62	0.47		0.52	0.26	0.22	0.36
Intangible Assets	0.57	0.93	0.13	0.22	-0.08	0.0	0.95	0.38	-0.21	0.71	0.09	-0.27	0.43	-0.05	0.88	0.25	0.13	-0.57	0.67	0.88	0.02	0.52		0.67	0.06	0.17
Accounts Payable	0.37	0.59	0.38	0.11	-0.2	0.17	0.63	0.12	-0.25	0.54	-0.03	-0.53	0.34	-0.39	0.58	0.35	0.02	-0.26	0.49	0.56	-0.16	0.26	0.67		-0.26	-0.17
Common Stock	0.61	0.29	0.24	0.58	0.83	0.62	0.17	0.79	0.74	0.46	0.05	0.51	0.64	0.85	0.33	0.44	0.6	-0.64	0.43	0.42	0.73	0.22	0.06	-0.26		0.98
Common Stock Total Equity	0.62	0.37	0.25	0.62	0.79	0.56	0.25	0.82	0.71	0.48	0.05	0.47	0.66	0.84	0.38	0.45	0.69	-0.68	0.45	0.52	0.7	0.36	0.17	-0.17	0.98

Click cells to compare fundamentals

Baxter International Account Relationship Matchups

Baxter International fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	18.2B	20.0B	33.5B	28.3B	28.3B	16.2B
Short Long Term Debt Total	6.0B	6.8B	18.3B	17.2B	14.4B	15.1B
Other Current Liab	1.7B	1.7B	2.2B	1.9B	2.3B	1.6B
Total Current Liabilities	3.2B	3.3B	4.2B	4.7B	6.5B	3.8B
Total Stockholder Equity	7.9B	8.7B	9.1B	5.8B	8.4B	5.8B
Property Plant And Equipment Net	5.1B	5.3B	5.8B	5.5B	5.0B	4.3B
Net Debt	2.6B	3.1B	15.4B	15.5B	11.2B	11.7B
Retained Earnings	15.7B	16.3B	17.1B	14.1B	16.1B	16.9B
Cash	3.3B	3.7B	3.0B	1.7B	3.2B	1.7B
Non Current Assets Total	10.7B	11.6B	24.6B	20.3B	18.7B	9.6B
Non Currrent Assets Other	372M	512M	683M	584M	368M	685.5M
Cash And Short Term Investments	3.3B	3.7B	3.0B	1.7B	3.2B	1.8B
Net Receivables	1.9B	2.1B	2.7B	2.8B	2.7B	2.1B
Common Stock Shares Outstanding	519M	517M	508M	504M	506M	620.3M
Liabilities And Stockholders Equity	18.2B	20.0B	33.5B	28.3B	28.3B	16.2B
Non Current Liabilities Total	7.1B	8.0B	20.2B	17.6B	13.3B	14.0B
Other Current Assets	389M	342M	390M	399M	835M	484.9M
Other Stockholder Equity	(4.8B)	(5.0B)	(5.3B)	(5.1B)	(4.8B)	(4.6B)
Total Liab	10.3B	11.3B	24.4B	22.4B	19.8B	10.3B
Property Plant And Equipment Gross	5.1B	5.3B	12.4B	12.0B	11.7B	12.3B
Total Current Assets	7.5B	8.4B	8.9B	8.0B	9.6B	6.6B
Accumulated Other Comprehensive Income	(3.7B)	(3.3B)	(3.4B)	(3.8B)	(3.6B)	(3.4B)
Short Term Debt	642M	517M	639M	1.5B	2.8B	2.9B
Intangible Assets	1.5B	1.7B	7.8B	6.8B	6.1B	6.4B
Accounts Payable	892M	1.0B	1.2B	1.1B	1.2B	1.1B
Other Liab	1.7B	1.7B	2.5B	2.0B	2.3B	2.3B
Other Assets	983M	1.3B	835M	653M	587.7M	872.8M
Long Term Debt	4.8B	5.8B	17.1B	15.2B	11.1B	5.9B
Good Will	3.0B	3.2B	9.8B	6.8B	6.5B	3.3B
Treasury Stock	(10.8B)	(11.1B)	(11.5B)	(11.4B)	(10.3B)	(9.7B)
Property Plant Equipment	4.5B	4.7B	5.8B	5.5B	6.4B	5.4B
Noncontrolling Interest In Consolidated Entity	30M	37M	44M	62M	55.8M	29.9M
Retained Earnings Total Equity	15.7B	16.3B	17.1B	14.1B	16.2B	12.7B

Pair Trading with Baxter International

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Baxter International position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Baxter International will appreciate offsetting losses from the drop in the long position's value.

Moving together with Baxter Stock

0.7	EW	Edwards Lifesciences Corp	Pair Corr
0.74	ENSG	Ensign Group	Pair Corr

Moving against Baxter Stock

0.48

GKOS

Glaukos Corp

Pair Corr

The ability to find closely correlated positions to Baxter International could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Baxter International when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Baxter International - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Baxter International to buy it.

The correlation of Baxter International is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Baxter International moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Baxter International moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Baxter International can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Baxter International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Baxter International's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Baxter International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Baxter International Stock:

How To Invest In Baxter

Details

Is Baxter Stock a good investment?

Details

What is Baxter International's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Baxter International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Baxter Stock please use our How to Invest in Baxter International guide.

Note that the Baxter International information on this page should be used as a complementary analysis to other Baxter International's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Baxter Stock analysis

When running Baxter International's price analysis, check to measure Baxter International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baxter International is operating at the current time. Most of Baxter International's value examination focuses on studying past and present price action to predict the probability of Baxter International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baxter International's price. Additionally, you may evaluate how the addition of Baxter International to your portfolios can decrease your overall portfolio volatility.

	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Transaction History View history of all your transactions and understand their impact on performance
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Volatility Analysis Get historical volatility and risk analysis based on latest market data

Is Baxter International's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baxter International. If investors know Baxter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baxter International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.20)

Dividend Share

1.16

Earnings Share

(0.08)

Revenue Per Share

29.387

Quarterly Revenue Growth

0.022

The market value of Baxter International is measured differently than its book value, which is the value of Baxter that is recorded on the company's balance sheet. Investors also form their own opinion of Baxter International's value that differs from its market value or its book value, called intrinsic value, which is Baxter International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baxter International's market value can be influenced by many factors that don't directly affect Baxter International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Baxter International's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baxter International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baxter International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Baxter Cost Of Revenue vs Current Deferred Revenue Analysis

Cost Of Revenue vs Current Deferred Revenue

Cost Of Revenue vs Current Deferred Revenue Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Current Deferred Revenue

Baxter International fundamental ratios Correlations

Baxter International Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Baxter International fundamental ratios Accounts

Pair Trading with Baxter International

Moving together with Baxter Stock

Moving against Baxter Stock

Complementary Tools for Baxter Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 0.99	Short Long Term Debt Total
Non Current Liabilities Total	+ 0.98	Short Long Term Debt Total
Common Stock Total Equity	+ 0.98	Common Stock
Total Liab	+ 0.97	Total Assets
Non Current Assets Total	+ 0.96	Total Assets
Property Plant And Equipment Gross	+ 0.96	Short Long Term Debt Total

Other Stockholder Equity	- 0.9	Retained Earnings
Common Stock Total Equity	- 0.68	Other Stockholder Equity
Property Plant And Equipment Gross	- 0.66	Other Stockholder Equity
Common Stock	- 0.64	Other Stockholder Equity
Other Stockholder Equity	- 0.64	Short Long Term Debt Total
Other Stockholder Equity	- 0.61	Non Current Liabilities Total